RET and medullary thyroid gland carcinoma: Ellipticine and its derivatives NSC311152 and NSC311153 have been demonstrated to suppress the proliferation of the MTC TT cells by reducing the RET protein expression through the stabilization of the G-quadruplex structure formed within the RET promoter region [36].